News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- Humira patents take center stage as House panel targets AbbVie pricing
- American skeptics fuel ongoing pharma 'trust deficit' despite pandemic gains, research finds
- STAT+: Your money or else: Some drug makers could be ‘highly’ susceptible to ransomware attacks
- STAT+: Google debuts an AI-powered app to analyze skin conditions
- STAT+: Atlas Venture launches another biotech to tackle vision loss
- Sarepta shares rally on early DMD data that also reveals 2 serious, 79 mild side effects
- Sarepta's Duchenne gene therapy clears study hurdle, although questions linger
- Bristol Myers pays Agenus $200M for drug aimed at top immunotherapy target
- Microsoft's VC arm leads $21M investment in Artificial’s lab automation platform
- Novartis challenge to Amgen's Enbrel patents ends at Supreme Court's door
- STAT+: Democrats call on FTC to investigate AbbVie’s Humira pricing strategy
- Merck KGaA's new CEO shakes up U.S. leadership to spark sales of promising drugs
- Laser-sensor startup Atonarp nets $50M to chase chemistry-free point-of-care diagnostics
- STAT+: STAT+ Conversations: What statistics mean for the Covid-19 vaccines
- 7wireVentures, incubator of digital health giant Livongo, launches $150M consumer health fund